January 08, 2025 06:10 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
Cipla's generic version of Remdesivir to be cheapest among rivals: Report

Cipla's generic version of Remdesivir to be cheapest among rivals: Report

Jul 09, 2020, at 05:39 am

Bengaluru/IBNS: Indian drug company Cipla has priced its generic version of Remdesivir, named Cipremi, at Rs 4,000 or USD 53.34 per 100 mg vial, making it the lowest priced versions of the COVID-19 treatment, a Reuters report said.

Cipla Limited launches generic remdesivir ‘Cipremi’ to fight COVID-19

Cipla Limited launches generic remdesivir ‘Cipremi’ to fight COVID-19

Jun 22, 2020, at 05:26 pm

New Delhi: Homegrown pharma major Cipla Limited on Monday announced the launch of remdesivir under its brand name Cipremi.